Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nuvo Pharmaceuticals Inc MRVFF

Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.


OTCQX:MRVFF - Post by User

Bullboard Posts
Comment by longondmxon Jul 11, 2006 1:13pm
630 Views
Post# 11088353

RE: Who Clarus is....

RE: Who Clarus is....Here is my take on things...purely "speculative". Nuvo already has the FDA submission ready to go, but may be waiting to ink a deal with a prospective partner before sending it off. I have a feeling that a deal with a partner is just about done...If you recall the AGM, there was mention that there were more than a few prospective partners in talks...I am sure there has been a lot talk happening and we will soon see the results of same. It would mean that much more to the investing community to have a partner to go at it with the FDA submission...not that I think it will make a difference with the FDA decision (because that should not be an issue) BUT because the investment community will see it as a big positive...eliminating any remaining doubt anyone may have. And this will be great for us shareholders. Afterall, we all know that a submission is coming...what would be a huge surprise is if the announcement of the submission happened at the same time a partner was announced, especially if it a big partner. Pennsaid with the right marketing campaign in the US will be huge. I have waited over 6 years, I can certainly wait another one. I agree also with the thought that the coverage was initiated just prior to a big news release...certainly will bode well with Clarus clients.
Bullboard Posts